RESEARCH

Stilul de viață dezechilibrat: legătura dintre obezitate și afecțiunile psihiatrice

Unbalanced lifestyle: the link between obesity and psychiatric conditions

Data publicării: 13 Noiembrie 2025
Data primire articol: 10 Octombrie 2025
Data acceptare articol: 04 Noiembrie 2025
Editorial Group: MEDICHUB MEDIA
10.26416/Psih.83.4.2025
Descarcă pdf

Abstract

Obesity, a burden on the global medical system, is defined by the presence of excess adipose tissue, with negative effects on health. Representing a chronic pathology, with negative multisystemic effects, obesity shows alarming increases in all age groups and in all geographical areas, thus becoming a global pandemic. The negative consequences of obesity are multiple, hypertension, atherosclerosis, metabolic syndrome, type 2 diabetes, dyslipidemia or insulin resistance being the most common threats that come to mind when faced with an overweight or obese patient, but the psychiatric pathologies caused by excess weight often remain in the shadows, a totally erroneous attitude. In reality, depression and obesity define interwoven pathologies, and are based on the same risk factors: the changes that have occurred in lifestyle in recent years. Specialized studies reveal that biomarkers recognized in obesity are the basis of the mechanisms that cause depression. It is also suggested that they may be used as markers in the assessment and therapeutic management of depressive disorders. Through this work, we want to draw attention to psychiatric disorders that appear silently in the life of obese patients, but are an essential pillar for effective therapeutic management of obesity. We also want to join the global fight against obesity and, once again, to raise the alarm about this global health issue. 



Keywords
obesitypsychiatric evaluationeffective managementprevention

Rezumat

Obezitatea, o povară a sistemului medical mondial, este definită de prezența țesutului adipos în exces, cu efecte negative asupra stării de sănătate. Fiind o patologie cronică şi cu efecte negative multisistemice, obezitatea prezintă creșteri alarmante la toate grupele de vârstă și în toate zonele geografice, devenind astfel o pandemie la nivel global. Consecințele negative ale obezității sunt multiple, hipertensiunea arterială, ateroscleroza, sindromul metabolic, diabetul zaharat de tip 2, dislipidemia şi rezistenţa la insulină fiind cele mai frecvente amenințări care ne vin în minte atunci când suntem puși în faţa unui pacient supraponderal sau obez, însă patologiile din zona psihiatrică determinate de excesul de greutate rămân adesea în umbră, o atitudine greşită. În realitate, depresia si obezitatea definesc patologii intercalate şi care au la bază aceiași factori de risc: modificările apărute în stilul de viață în ultimii ani. Studii de specialitate relevă faptul că există biomarkeri recunoscuţi în obezitate sunt stau la baza mecanismelor ce cauzează depresie. De asemenea, se sugerează posibilitatea ca aceștia să fie utilizați şi ca markeri în evaluarea şi managementul terapeutic al tulburărilor depresive. Prin intermediul acestei lucrări, dorim să atragem atenția asupra afecțiunilor psihiatrice care apar, tăcut, în viaţa pacientului obez, dar care sunt un pilon esențial pentru managementul terapeutic eficient al obezității. De asemenea, dorim să ne alăturam luptei mondiale împotriva obezității şi să tragem încă o dată un semnal de alarmă privind această problemă de sănătate la nivel mondial. 

Cuvinte Cheie
obezitateevaluare psihiatricămanagement eficientprevenție

Introduction

Obesity, a global pandemic, has shown alarming increases in recent decades. It is estimated that, by 2030, approximately one billion people globally will be diagnosed with obesity, given that, currently, worldwide, there are approximately 300 million people diagnosed with depression(1). According to specialized studies, the female sex is more prone to depression and obesity, a possible risk factor being pregnancy, for both chronic pathologies(2,3).

The diagnosis and staging of obesity are made easiest and cheapest with the help of anthropometric indices, of which, the one that has gained ground, being most widely used today, is the Body Mass Index (BMI). Defined as a chronic pathology, obesity is associated with an inflammatory status that translates into an increased secretion of proinflammatory cytokines, and these cytokines can have negative effects on the expression of neurotransmitters(4-6).

Secondary obesity, which is based on an unbalanced lifestyle, is the main cause of obesity, thus, the changes brought about in recent decades, in all branches of lifestyle, have led to a constant and alarming increase in obesity cases, with gloomy forecasts for the coming years, in the absence of effective measures to reduce and prevent this pandemic(7,8).

It is important to understand that, when we talk about an unbalanced lifestyle, we must take into account multiple factors which, when summed up, lead to the percentages that have transformed obesity into a burden on the medical system worldwide(9,10). Thus, excessive calorie consumption in relation to necessity, the multitude of processed food offers and junk food, the lack of quantitative and qualitative sleep, the lack of physical exercise, or too much time allocated to electronic devices, in contrast to the time spent in nature and with family members or friends, are key elements in the installation of obesity(9). This is why it is not professional to focus only on the nutritional aspect when dealing with an obese patient; failure to identify other predisposing factors leads to their failure to be resolved and, ultimately, to the failure of the therapeutic plan.

Chronic stress is a risk factor for obesity, but it is also the most common disorder associated with depression. Cortisone, eliminated in stressful situations, when chronically present, interferes with carbohydrate metabolism, leading to the installation of insulin resistance(5).

The obese patient needs a multidisciplinary team in which the psychiatrist must be part, due to the fact that obesity – especially when it has been present for a long period – inevitably associates disorders in this area which, if unidentified, will make the weight loss process more difficult and, at the same time, will deepen.

Low self-esteem, isolation and mild-to-severe depression are the main psychiatric disorders that accompany the obese patient. If we return to the factors responsible for lifestyle – namely, the quality and quantity of sleep, the absence of entourage, the lack of time spent in nature –, we can conclude that the psychiatric disorder has a double origin, both in the factors favoring obesity and in obesity itself.

It is essential to understand that depression, as well as the rest of the psychiatric disorders, is based on multiple mechanisms, but these two – depression and obesity – are often correlated, and in recent years, both pathologies have recorded significant increases(11,12).

The purpose of this paper is to draw attention to the psychiatric disorders that appear silently in the life of the obese patient, but are an essential pillar for the effective therapeutic management of obesity, and also to underscore the fact that depression and obesity represent two bidirectional chronic pathologies, being necessary for both to be treated. We also want to join the global fight against obesity and to – once again – raise the alarm about this global health issue. Last but not least, we emphasize the need for a multidisciplinary therapeutic management in front of an obese patient.

Materials and method

This narrative review aimed to synthesize evidence-based on guidelines and clinical trials about the impact of obesity in the psychiatric field. A structured search was performed in PubMed, Scholar Academic and Google Scholar for records published between 2020 and 2025. The inclusion criteria included peer-reviewed publications in English reporting randomized controlled trials, systematic reviews, meta-analyses, large observational cohorts or clinical guidelines on the impact of obesity on psychiatric health. The search terms used were: obesity, depression, psychiatric disorder and obesity, behavioral therapy.

Results and discussion

According to the analysis, there is a reciprocal relationship between obesity and depression, resulting from all studies, and the basis of this relationship is favored by the lifestyle of modern man(4,11).

The treatment of obesity comes with the reduction of mental symptoms, a visible action also in the case of the therapeutic management of pathologies in the depressive sphere. It should be remembered that, in both pathologies, the patient-centered approach is essential for an efficient management, and the existence of exogenous factors, an integrated part of the unbalanced lifestyle, must be carefully analyzed in each patient(13,14).

Although they are based on different mechanisms of production, depression and obesity also associate certain common characteristics, the chronic inflammation found in obesity, against the background of excess weight, representing an essential pillar in the installation of depression(11,15,16).

There are studies suggesting that the HPA axis becomes hyperactive in the presence of biomarkers associated with obesity – namely, adiponectin, leptin, ghrelin and resistin(17-19). It is well known that, in depressive pathologies, the HPA axis is hyperactive, thus this mechanism can also explain the link between obesity and depression. Excess adipose tissue is associated with reduced levels of adiponectin, which has anti-inflammatory properties, partially explaining the inflammatory status in obesity(15). The imbalance of the HTA axis also occurs due to the fact that leptin and resistin have increased values; thus, in the presence of an unbalanced HPA axis, an excess of cortisol is produced, which is identified in the etiology of depression(11).

Low adiponectin levels have been correlated with the severity of major depressive disorder. Thus, Islam et al. (2022) suggest that adiponectin levels could be a useful marker in detecting the risk of depression, because adiponectin levels were also reduced in recurrent disorders, but also in evaluating therapeutic management(20,21).

Resistin – another well-known biomarker in obesity, because it shows increased values ​​in these patients – has the role of reducing the levels of dopamine and noradrenaline and, through these mechanisms, it could individually contribute to the installation of depressive pathologies(18,19,22).

Inflammation caused by excess weight leads to increased levels of proinflammatory cytokines, in contrast to the reduction of anti-inflammatory ones. Therefore, the idea of ​​using IL-6, TNF-alpha and CRP, present in obesity in high percentages, as markers in depression is being discussed, due to the fact that their high presence in the body leads to an amplification of the clinical picture of depressive disorders. Luppino et al. reveal that the risk of developing depression in obese patients was 55%, and those with depression had a 58% risk of developing obesity.(23). Also, obese people have a 32% higher risk of developing depression compared to normal-weight people(24).

Female sex is more often incriminated in the statistics of these two chronic pathologies, obesity and depression. Pregnancy is the time when women have a high chance of developing depression, because of the major physical and hormonal changes their body goes through. Therefore, health professionals should pay attention to signs of depression during pregnancy, not just postpartum, when it is well known that the risk of developing depression is high, but unfortunately, it is not diagnosed and treated in all cases, from the beginning(3,5,25).

The excess weight that a woman often remains with after pregnancy is a major contributing factor to triggering depression in the first postpartum year. Not only is the mother affected, but the entire family, and the infant feels the hardest, because he spends the most time with the mother and, according to specialized studies, a depressed mother leads to an inharmonious development (both physically and psycho-emotionally) of the newborn and, subsequently, for the infant(27-29). Thus, in front of a pregnant woman or a patient who has just given birth, a multidisciplinary team is also necessary for the prevention of chronic problems or for the therapeutic success.

Lack of sufficient quality and quantity of sleep leads to raising levels of ghrelin, a hormone known to be associated with increased food intake. At the same time, interrupted sleep leads to insulin resistance, which in turn is a contributing factor to depression and obesity(5).

Intensely analyzed in recent decades, the imbalance of the intestinal microbiome is the basis of multiple pathologies. The evidence of the bidirectional link between the two pathologies – depression and obesity – is also stabilized by prebiotics and probiotics. According to studies, strains of Lactobacillus and Bifidobacterium have associated positive changes in both conditions(29).

Psychological trauma is a predisposing factor for eating disorders, which is why it is important to take a detailed history with an obese patient, and then, regardless of the nature of the specialization, to include a psychiatric consultant as part of the therapeutic management. A systematic review showed a 90% association between trauma and eating disorders(30).

A study conducted in Seattle analyzed the mood of subjects after meals high in carbohydrates, finding that they increased the intensity of depressive disorders(31).

Another study analyzed the effect of physical activity on depression, and the symptoms were reduced in patients who used to do exercises(32).

Lifestyle change remains the essential pillar in the face of obese patients and, regardless of whether they associate depression or not, psychiatric consultation is important for lifestyle change. According to studies, self-motivation is the most important factor responsible for lifestyle change, and for sufficient self-motivation to change, sometimes appropriate therapies are necessary. Nutritional psychoeducation and motivational interviewing are effective methods to increase self-motivation, and studies have shown significantly better results in patients with a high level of motivation(33).

Conclusions

The obese patient requires a multidisciplinary approach, and psychiatric consultation is the essential link for the favorable evolution of the case.

Obesity is a chronic disease, responsible for numerous other chronic pathologies that transform this lifestyle imbalance into a significant risk factor for morbidity and mortality, in the 21st century, also becoming a burden for the global medical system and causing huge costs.

The association between obesity and depression is a reality that requires appropriate attention. Also, biomarkers known in obesity are suggested as possible prognostic markers for evaluation and therapeutic management in depression. In this direction, extensive studies are needed, on significant cohorts of patients.

We believe it is time to intervene promptly through health policies for prevention, but also for treatment, in those cases where obesity is already installed, and apart from these policies, let us not omit the psychiatrist’s role for the essential therapeutic management.   

 

Corresponding author: Dragoș Mandroc E-mail: mandrocd@gamil.com

Conflict of interest: none declared.

Financial support: none declared.

This work is permanently accessible online free of charge and published under the CC-BY licence.

Bibliografie


 

  1. Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol. 2017;2(7):e17. 

  2. Fransson E, Sörensen F, Kunovac Kallak T, et al. Maternal perinatal depressive symptoms trajectories and impact on toddler behavior – the importance of symptom duration and maternal bonding. J Affect Disord. 2020;273:542-551. 

  3. Gila-Díaz A, Carrillo GH, López de Pablo ÁL, Arribas SM, Ramiro-Cortijo D. Association between Maternal Postpartum Depression, Stress, Optimism, and Breastfeeding Pattern in the First Six Months. Int J Environ Res Public Health. 2020;17(19):7153. 

  4. Dębski J, Przybyłowski J, Skibiak K, Czerwińska M, Walędziak M, Różańska-Walędziak A. Depression and Obesity – Do We Know Everything about It? A Narrative Review. Nutrients. 2024;16(19):3383. 

  5. Borgland SL. Can treatment of obesity reduce depression or vice versa?. J Psychiatry Neurosci JPN. 2021;46(2):E313-E318. 

  6. Lasselin J, Benson S, Hebebrand J, et al. Immunological and behavioral responses to in vivo lipopolysaccharide administration in young and healthy obese and normal-weight humans. Brain Behav Immun. 2020;88:283-293. 

  7. Androutsos O, Perperidi M, Georgiou C, Chouliaras G. Lifestyle Changes and Determinants of Children’s and Adolescents’ Body Weight Increase during the First COVID-19 Lockdown in Greece: The COV-EAT Study. Nutrients. 2021;13(3):930. 

  8. Kinlen D, Cody D, O’Shea D. Complications of obesity. QJM Mon J Assoc Physicians. 2018;111(7):437-443. 

  9. Jankowska P. The Role of Stress and Mental Health in Obesity. Obesities. 2025;5(2):20. 

  10. Barrera AZ, Wickham RE, Muñoz RF. Online prevention of postpartum depression for Spanish- and English-speaking pregnant women: A pilot randomized controlled trial. Internet Interv. 2015;2(3):257-265. 

  11. Oracz AJ, Zwierz M, Naumowicz M, Suprunowicz M, Waszkiewicz N. Relationship Between Obesity and Depression Considering the Inflammatory Theory. Int J Mol Sci. 2025;26(11):4966. 

  12. Kokka I, Mourikis I, Bacopoulou F. Psychiatric Disorders and Obesity in Childhood and Adolescence – A Systematic Review of Cross-Sectional Studies. Children. 2023;10(2):285. 

  13. A new era in obesity management. Nature Reviews Gastroenterology & Hepatology. Accessed July 11, 2024. https://www.nature.com/articles/s41575-023-00887-9

  14. Jha MK, Wakhlu S, Dronamraju N, Minhajuddin A, Greer TL, Trivedi MH. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial. J Affect Disord. 2018;234:34-37. 

  15. Shelton RC, Miller AH. Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci. 2011;13(1):41-53. 

  16. Gałecki P, Talarowska M. Inflammatory theory of depression. Psychiatr Pol. 2018;52(3):437-447. 

  17. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001;86(10):5083-5086. 

  18. Weber-Hamann B, Kratzsch J, Kopf D, et al. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. J Psychiatr Res. 2007;41(3-4):344-350. 

  19. Liu J, Guo M, Zhang D, et al. Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity. Proc Natl Acad Sci U S A. 2012;109(30):12248-12253. 

  20. Islam S, Islam T, Nahar Z, et al. Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study. PloS One. 2022;17(11):e0276619.

  21. Grimm MC, Elsbury SK, Pavli P, Doe WF. Interleukin 8: cells of origin in inflammatory bowel disease. Gut. 1996;38(1):90-98.

  22. Lehto SM, Huotari A, Niskanen L, et al. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand. 2010;121(3):209-215. 

  23. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010 Mar;67 (3):220-9.

  24. Pereira-Miranda E, Costa PRF, Queiroz VAO, Pereira-Santos M, Santana MLP. Overweight and Obesity Associated with Higher Depression Prevalence in Adults: A Systematic Review and Meta-Analysis. J Am Coll Nutr. 2017;36(3):223-233. 

  25. Beck CT. Postpartum depression: it isn’t just the blues. Am J Nurs. 2006;106(5):40-50; quiz 50-51. 

  26. Duko B, Wolde D, Alemayehu Y. The epidemiology of postnatal depression in Ethiopia: a systematic review and meta-analysis. Reprod Health. 2020;17(1):180. 

  27. Rogers A, Obst S, Teague SJ, et al. Association Between Maternal Perinatal Depression and Anxiety and Child and Adolescent Development: A Meta-analysis. JAMA Pediatr. 2020;174(11):1082-1092. 

  28. Dennis CL, Dowswell T. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev. 2013; 2013(2):CD001134. 

  29. Ben Othman R, Ben Amor N, Mahjoub F, et al. A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects. Endocrinol Diabetes Metab. 2023;6(2):e402. 

  30. Palmisano GL, Innamorati M, Vanderlinden J. Life adverse experiences in relation with obesity and binge eating disorder: A systematic review. J Behav Addict. 2016;5(1):11-31. 

  31. Breymeyer KL, Lampe JW, McGregor BA, Neuhouser ML. Subjective mood and energy levels of healthy weight and overweight/obese healthy adults on high-and low-glycemic load experimental diets. Appetite. 2016;107:253-259. 

  32. Vancini RL, Rayes ABR, Lira CAB de, Sarro KJ, Andrade MS. Pilates and aerobic training improve levels of depression, anxiety and quality of life in overweight and obese individuals. Arq Neuropsiquiatr. 2017;75(12):850-857. 

  33. Barnes RD, Ivezaj V, Martino S, Pittman BP, Paris M, Grilo CM. 12 Months later: Motivational interviewing plus nutrition psychoeducation for weight loss in primary care. Eat Weight Disord EWD. 2021;26(6):2077-2081. 

Articole din ediția curentă

EVENTS

Retrospectiva 2025 a evenimentelor știinţifice în domeniul psihiatriei și sănătăţii mintale din România

Conferința Națională Interdisciplinară „Sănătate mintală” – 28 ianuarie 2025, online Organizator: Alianța Română de Prevenție a Suicidului...
BOOK REVIEW

Psihologie medicală

Doina Cosman
Lucrarea Psihologie medicală, semnată de doamna profesor dr. Doina Cosman, apărută în ediție revizuită și adăugită anul acesta la Editura Polirom, este, prin anvergura demersului explorativ și prin complexitatea perspectivei oferite asupra psihismului uman, un tratat fundamental dedicat formării și dezvoltări...
PSYCHOPATHOLOGY

Dialoguri între artă și psihiatrie (II) – o incursiune patografică în Postimpresionism

Octavian Vasiliu
Explorarea patografică inițiată în prima parte a acestui studiu este continuată cu un alt grup de artiști celebri, de această dată postimpresioniști, care au fost activi la sfârșitul secolului al XIX-lea și începutul sec...
Articole din edițiile anterioare

RESEARCH

De la internarea în secția de psihiatrie la cea din unitățile de terapie intensivă: profiluri clinice, factori determinanți și rezultate într-un spital universitar din România

Camelia Sandu, Nada Mosebach, Rebeca-Isabela Molnar, Adriana Mihai
Introducere. Pacienții psihiatrici se prezintă adesea cu probleme medicale complexe care necesită transferul în unitățile de terap...
UP-TO-DATE

Pleuran (beta-glucan extras din Pleurotus ostreatus) – imunoceutic în patologiile respiratorii pediatrice

Heidrun Adumitrăchioaiei
Beneficiile unui sistem imunitar funcțional au devenit un su­biect de interes în ultimii ani, atât pentru specialiștii din domeniul sănătății, cât și pentru populația generală. ...
EDITORIAL

Pandemia obezității – povara sistemului medical global

Heidrun Adumitrăchioaiei, Laura‑Bogdana Nat, Mihai Hărăguș, Ioana-Mariana Marchiș
Obezitatea reprezintă o reală problemă de sănătate la nivel mondial, din cauza creșterilor alarmante din ultimele decenii, dar și a faptului că previziunile sunt nefaste, în lipsa unor acțiuni rapide și eficiente....